Story perspectives

ByHeart Closes Plant After Serious Safety Violations Uncovered

11/16/2025

29 4

Summary

Story summary

ByHeart closed its manufacturing plant in Reading, Pennsylvania, following serious safety violations uncovered by federal investigators.
The Food and Drug Administration (FDA) inspection revealed a leaking roof and over 2,700 dead insects in the production area.
Although these findings did not involve the plants that produced the recalled formula, experts raised concerns about ByHeart's safety record.
Previous inspections found a deadly bacterium in the processing area and a finished product, which the company attributed to laboratory errors.
The FDA rated the inspection with the highest level of concern.

1 of 1

Story summary

ByHeart closed its manufacturing plant in Reading, Pennsylvania, following serious safety violations uncovered by federal investigators.
The Food and Drug Administration (FDA) inspection revealed a leaking roof and over 2,700 dead insects in the production area.
Although these findings did not involve the plants that produced the recalled formula, experts raised concerns about ByHeart's safety record.
Previous inspections found a deadly bacterium in the processing area and a finished product, which the company attributed to laboratory errors.
The FDA rated the inspection with the highest level of concern.